Sherry Shu-Jung Hu1, Ya-Wei Liu, Lung Yu. 1. Cannabinoid Signaling Laboratory, Department of Psychology, National Cheng Kung University, 1 University Rd., Tainan, 70101, Taiwan, shujungh@mail.ncku.edu.tw.
Abstract
RATIONALE: Cannabinoid CB1 receptors are implicated in various forms of learning and memory, including acquisition and reinstatement of cocaine-associated memory. However, roles of CB1 receptors in consolidation and extinction processes of cocaine-associated memory and the brain areas potentially involved remain unknown. OBJECTIVE: This study examined the effect of rimonabant, a CB1 receptor antagonist, administered systemically or directly into the medial prefrontal cortex (mPFC) on memory consolidation and extinction of cocaine-induced conditioned place preference (CPP). MATERIALS AND METHODS: Male C57BL/6J mice were trained to acquire cocaine-induced CPP. Rimonabant (0.1-3 mg/kg, i.p. or 1.5 μg bilaterally in the mPFC) or vehicle was administered either immediately after each CPP training (consolidation) or forced extinction (extinction) trial. Cocaine-induced CPP was tested after training, extinction, or cocaine priming. RESULTS: Systemic or intra-mPFC administration of rimonabant impaired consolidation of CPP induced by a high dose (20 or 40 mg/kg) of cocaine but facilitated that induced by a low dose (2.5, 5, or 10 mg/kg). Moreover, systemic or intra-mPFC administration of rimonabant enhanced extinction of CPP memory induced by a high-dose (20 mg/kg) cocaine. CONCLUSION: Our results suggest that antagonism of CB1 receptors in the mPFC bidirectionally modulates consolidation but facilitates extinction of cocaine-induced CPP memory. Therefore, CB1 receptor blockade with the concomitant extinction behavioral procedure may hint important therapeutic intervention strategies for the heavy cocaine addicts in a clinical setting.
RATIONALE: Cannabinoid CB1 receptors are implicated in various forms of learning and memory, including acquisition and reinstatement of cocaine-associated memory. However, roles of CB1 receptors in consolidation and extinction processes of cocaine-associated memory and the brain areas potentially involved remain unknown. OBJECTIVE: This study examined the effect of rimonabant, a CB1 receptor antagonist, administered systemically or directly into the medial prefrontal cortex (mPFC) on memory consolidation and extinction of cocaine-induced conditioned place preference (CPP). MATERIALS AND METHODS: Male C57BL/6J mice were trained to acquire cocaine-induced CPP. Rimonabant (0.1-3 mg/kg, i.p. or 1.5 μg bilaterally in the mPFC) or vehicle was administered either immediately after each CPP training (consolidation) or forced extinction (extinction) trial. Cocaine-induced CPP was tested after training, extinction, or cocaine priming. RESULTS: Systemic or intra-mPFC administration of rimonabant impaired consolidation of CPP induced by a high dose (20 or 40 mg/kg) of cocaine but facilitated that induced by a low dose (2.5, 5, or 10 mg/kg). Moreover, systemic or intra-mPFC administration of rimonabant enhanced extinction of CPP memory induced by a high-dose (20 mg/kg) cocaine. CONCLUSION: Our results suggest that antagonism of CB1 receptors in the mPFC bidirectionally modulates consolidation but facilitates extinction of cocaine-induced CPP memory. Therefore, CB1 receptor blockade with the concomitant extinction behavioral procedure may hint important therapeutic intervention strategies for the heavy cocaine addicts in a clinical setting.
Authors: T J De Vries; Y Shaham; J R Homberg; H Crombag; K Schuurman; J Dieben; L J Vanderschuren; A N Schoffelmeer Journal: Nat Med Date: 2001-10 Impact factor: 53.440
Authors: Neal C Gehani; Julia W Nalwalk; Raj K Razdan; Billy R Martin; Xufung Sun; Mark Wentland; Mary E Abood; Lindsay B Hough Journal: J Pain Date: 2007-07-23 Impact factor: 5.820
Authors: Francisco Ródenas-González; María Del Carmen Blanco-Gandía; María Pascual; Irene Molari; Consuelo Guerri; José Miñarro López; Marta Rodríguez-Arias Journal: Psychopharmacology (Berl) Date: 2021-03-31 Impact factor: 4.530
Authors: Jadna B Lopes; Juliana R Bastos; Rayssa B Costa; Daniele C Aguiar; Fabrício A Moreira Journal: Psychopharmacology (Berl) Date: 2019-10-30 Impact factor: 4.530
Authors: Andrea S Guzman; Maria P Avalos; Laura N De Giovanni; Pia V Euliarte; Marianela A Sanchez; Bethania Mongi-Bragato; Daiana Rigoni; Flavia A Bollati; Miriam B Virgolini; Liliana M Cancela Journal: Sci Rep Date: 2021-06-21 Impact factor: 4.379
Authors: M Rodríguez-Arias; C Roger-Sánchez; I Vilanova; N Revert; C Manzanedo; J Miñarro; M A Aguilar Journal: Neural Plast Date: 2015-12-31 Impact factor: 3.599